Free Webcast: Abbott, Genentech on Minimizing Contract Partnership Risk

Oct. 22, 2010 - PRLog -- Partnerships between drug product sponsors and contract manufacturers are under increasing regulatory and public scrutiny. As expectations for product quality and safety have risen, contract partners must maintain a seamless and compliant working relationship—with the ultimate goal of jointly minimizing risk via comprehensive risk assessment, and effective risk control.

This one-hour program, at 11 a.m. ET (US) on November 2, will feature presentations by three industry experts on the topic, followed by a brief Q&A with members of the web audience.

Speakers include:

Russ Somma, Principal, SommaTech Consulting LLC
“Towards Partnerships Based on Risk Knowledge”

Richard Poska, Director, Global Regulatory Affairs, Strategic CMC Initiatives, Abbott Laboratories
“Regulatory CMC Risk Assessment Between Contract Partners”

Franco Pasquale, Senior Manager, Roche Contract Manufacturing Operating Unit
“Roche/Genentech's Risk-Based Approach To CMO Management”

Moderator: Paul Thomas, Senior Editor, Pharmaceutical Manufacturing Magazine

Join us for an excellent, engaging program.